General Information of the Compound
| Compound ID |
CP0372351
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2,2-diphenyl-N-(3-phenylpropyl)acetamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
2,2-diphenyl-N-(3-phenylpropyl)acetamide
AC1M5U8J
AKOS001062446
BDBM50263151
CHEMBL476336
MCULE-9627491940
MolPort-003-249-505
N-(3-Phenyl)propyl-2,2-diphenylacetamide
N-(3-Phenylpropyl)-2,2-diphenylacetamide
ST50913753
STK437441
Z26437312
ZINC3269206
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H23NO
|
||||||||||||||||||
| Molecular Weight |
329.443
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCCCc1ccccc1)C(c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H23NO/c25-23(24-18-10-13-19-11-4-1-5-12-19)22(20-14-6-2-7-15-20)21-16-8-3-9-17-21/h1-9,11-12,14-17,22H,10,13,18H2,(H,24,25)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GGASESVHBWYDKY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2
Clinical Information about the Compound